首页 > 最新文献

Journal of obstetrics and gynaecology Canada最新文献

英文 中文
Dispelling Confusion About the Effect of Episiotomy With Operative Vaginal Delivery: A Reply to “Large Databases Cannot Illuminate Practice Variation in the Use of Episiotomy” 消除外阴切开术对阴道手术分娩影响的困惑:对 "大型数据库无法说明使用外阴切开术的实践差异 "的答复
IF 2 Q2 OBSTETRICS & GYNECOLOGY Pub Date : 2024-08-01 DOI: 10.1016/j.jogc.2024.102589
Giulia M. Muraca PhD, MPH , Sarka Lisonkova MD, PhD , K.S. Joseph MD, PhD
{"title":"Dispelling Confusion About the Effect of Episiotomy With Operative Vaginal Delivery: A Reply to “Large Databases Cannot Illuminate Practice Variation in the Use of Episiotomy”","authors":"Giulia M. Muraca PhD, MPH , Sarka Lisonkova MD, PhD , K.S. Joseph MD, PhD","doi":"10.1016/j.jogc.2024.102589","DOIUrl":"10.1016/j.jogc.2024.102589","url":null,"abstract":"","PeriodicalId":16688,"journal":{"name":"Journal of obstetrics and gynaecology Canada","volume":null,"pages":null},"PeriodicalIF":2.0,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142048086","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Directive clinique no 452 : Diagnostic et prise en charge de la cholestase intrahépatique de la grossesse 临床指南第 452 号:妊娠期肝内胆汁淤积症的诊断和管理。
IF 2 Q2 OBSTETRICS & GYNECOLOGY Pub Date : 2024-08-01 DOI: 10.1016/j.jogc.2024.102619
Sebastian R. Hobson M.D., Ph. D., Elissa R. Cohen M.D., M.A., Shital Gandhi M.D., M. Sc. (santé publique), Venu Jain M.D., Ph. D., Kirsten M. Niles M.D., Ph. D., Marie-Ève Roy-Lacroix M.D., Bi Lan Wo M.D.
<div><h3>Objectif</h3><p>Résumer les données probantes actuelles et formuler des recommandations pour le diagnostic et la prise en charge de la cholestase intrahépatique de la grossesse.</p></div><div><h3>Population cible</h3><p>Personnes enceintes atteintes de cholestase intrahépatique de la grossesse.</p></div><div><h3>Options</h3><p>Diagnostiquer la cholestase par le dosage des acides biliaires à jeun ou non, classer la gravité de l’atteinte, déterminer le traitement à offrir, établir la méthode de surveillance du bien-être fœtal, déterminer quand procéder à un accouchement planifié.</p></div><div><h3>Bénéfices, risques et coûts</h3><p>Les personnes atteintes de cholestase intrahépatique de la grossesse présentent un risque accru d’issues périnatales défavorables (naissance prématurée, détresse respiratoire néonatale et hospitalisation en unité de soins intensifs néonatale), et de mortinaissance lorsque le taux d’acides biliaires est de 100 μmol/L ou plus. Il existe une inégalité dans la disponibilité des bilans d’acides biliaires et l’accès rapide aux résultats. Une incertitude règne quant à la manière de traiter et surveiller ces grossesses et de procéder à l’accouchement. L’optimisation des protocoles de diagnostic et de prise en charge peut améliorer les issues maternelles, fœtales et postnatales.</p></div><div><h3>Données probantes</h3><p>Des recherches ont été effectuées dans les bases de données Medline, PubMed, Embase et Cochrane Library, de leur création jusqu’à mars 2023, à partir de termes MeSH et de mots clés liés à la grossesse, à la cholestase intrahépatique de la grossesse, aux acides biliaires, au prurit, à l’acide ursodésoxycholique et à la mortinaissance. Le présent document est un résumé des données probantes et non pas une revue méthodologique.</p></div><div><h3>Méthodes de validation</h3><p>Les auteurs ont évalué la qualité des données probantes et la force des recommandations en utilisant le cadre méthodologique GRADE (Grading of Recommendations, Assessment, Development, and Evaluation). Voir l’<span><span>annexe A</span></span> (<span><span>tableau A1</span></span> pour les définitions et <span><span>tableau A2</span></span> pour l’interprétation des recommandations fortes et faibles).</p></div><div><h3>Professionnels concernés</h3><p>Professionnels de soins obstétricaux, y compris obstétriciens, médecins de famille, infirmières, sages-femmes, spécialistes en médecine fœto-maternelle et radiologistes.</p></div><div><h3>Résumé des médias sociaux</h3><p>La cholestase intrahépatique de la grossesse nécessite un bon diagnostic par dosage des acides biliaires non à jeun pour déterminer la prise en charge optimale et le moment de l’accouchement.</p></div><div><h3>DÉCLARATIONS SOMMAIRES</h3><p></p><ul><li><span>1.</span><span><p>La cholestase intrahépatique de la grossesse est un trouble gravidique fréquent qui se manifeste à la fin du deuxième trimestre ou au troisième trimestre (<em>moyenne</em>).</p></span></li><li><span>2.<
方案:通过空腹和非空腹胆汁酸试验诊断胆汁淤积症,对病情严重程度进行分级,确定应提供的治疗,建立监测胎儿健康的方法,确定何时进行计划分娩。益处、风险和成本:当胆汁酸水平达到或超过 100 μmol/L 时,妊娠肝内胆汁淤积症患者围产期不良结局(早产、新生儿呼吸窘迫和新生儿重症监护室住院)和死胎的风险会增加。在提供胆汁酸检测和快速获取结果方面存在不平等。如何治疗和监测这些妊娠以及如何分娩这些妊娠都存在不确定性。优化诊断和管理方案可改善孕产妇、胎儿和产后结果。筛选数据:使用与妊娠、妊娠肝内胆汁淤积症、胆汁酸、瘙痒、熊去氧胆酸和死胎相关的 MeSH 术语和关键词,对 Medline、PubMed、Embase 和 Cochrane 图书馆数据库进行了检索,检索期从开始到 2023 年 3 月。本文件为证据摘要,并非方法学综述。验证方法:作者采用 GRADE(建议、评估、发展和评价分级)框架评估了证据的质量和建议的力度。参见附录 A(表 A1 为定义,表 A2 为强建议和弱建议的解释)。相关专业人员:产科护理专业人员,包括产科医生、家庭医生、护士、助产士、母胎医学专家和放射科医生。社会媒体总结:妊娠肝内胆汁淤积症需要通过非空腹胆汁酸测定进行正确诊断,以确定最佳治疗方法和分娩时机。
{"title":"Directive clinique no 452 : Diagnostic et prise en charge de la cholestase intrahépatique de la grossesse","authors":"Sebastian R. Hobson M.D., Ph. D.,&nbsp;Elissa R. Cohen M.D., M.A.,&nbsp;Shital Gandhi M.D., M. Sc. (santé publique),&nbsp;Venu Jain M.D., Ph. D.,&nbsp;Kirsten M. Niles M.D., Ph. D.,&nbsp;Marie-Ève Roy-Lacroix M.D.,&nbsp;Bi Lan Wo M.D.","doi":"10.1016/j.jogc.2024.102619","DOIUrl":"10.1016/j.jogc.2024.102619","url":null,"abstract":"&lt;div&gt;&lt;h3&gt;Objectif&lt;/h3&gt;&lt;p&gt;Résumer les données probantes actuelles et formuler des recommandations pour le diagnostic et la prise en charge de la cholestase intrahépatique de la grossesse.&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Population cible&lt;/h3&gt;&lt;p&gt;Personnes enceintes atteintes de cholestase intrahépatique de la grossesse.&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Options&lt;/h3&gt;&lt;p&gt;Diagnostiquer la cholestase par le dosage des acides biliaires à jeun ou non, classer la gravité de l’atteinte, déterminer le traitement à offrir, établir la méthode de surveillance du bien-être fœtal, déterminer quand procéder à un accouchement planifié.&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Bénéfices, risques et coûts&lt;/h3&gt;&lt;p&gt;Les personnes atteintes de cholestase intrahépatique de la grossesse présentent un risque accru d’issues périnatales défavorables (naissance prématurée, détresse respiratoire néonatale et hospitalisation en unité de soins intensifs néonatale), et de mortinaissance lorsque le taux d’acides biliaires est de 100 μmol/L ou plus. Il existe une inégalité dans la disponibilité des bilans d’acides biliaires et l’accès rapide aux résultats. Une incertitude règne quant à la manière de traiter et surveiller ces grossesses et de procéder à l’accouchement. L’optimisation des protocoles de diagnostic et de prise en charge peut améliorer les issues maternelles, fœtales et postnatales.&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Données probantes&lt;/h3&gt;&lt;p&gt;Des recherches ont été effectuées dans les bases de données Medline, PubMed, Embase et Cochrane Library, de leur création jusqu’à mars 2023, à partir de termes MeSH et de mots clés liés à la grossesse, à la cholestase intrahépatique de la grossesse, aux acides biliaires, au prurit, à l’acide ursodésoxycholique et à la mortinaissance. Le présent document est un résumé des données probantes et non pas une revue méthodologique.&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Méthodes de validation&lt;/h3&gt;&lt;p&gt;Les auteurs ont évalué la qualité des données probantes et la force des recommandations en utilisant le cadre méthodologique GRADE (Grading of Recommendations, Assessment, Development, and Evaluation). Voir l’&lt;span&gt;&lt;span&gt;annexe A&lt;/span&gt;&lt;/span&gt; (&lt;span&gt;&lt;span&gt;tableau A1&lt;/span&gt;&lt;/span&gt; pour les définitions et &lt;span&gt;&lt;span&gt;tableau A2&lt;/span&gt;&lt;/span&gt; pour l’interprétation des recommandations fortes et faibles).&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Professionnels concernés&lt;/h3&gt;&lt;p&gt;Professionnels de soins obstétricaux, y compris obstétriciens, médecins de famille, infirmières, sages-femmes, spécialistes en médecine fœto-maternelle et radiologistes.&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Résumé des médias sociaux&lt;/h3&gt;&lt;p&gt;La cholestase intrahépatique de la grossesse nécessite un bon diagnostic par dosage des acides biliaires non à jeun pour déterminer la prise en charge optimale et le moment de l’accouchement.&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;DÉCLARATIONS SOMMAIRES&lt;/h3&gt;&lt;p&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;&lt;span&gt;1.&lt;/span&gt;&lt;span&gt;&lt;p&gt;La cholestase intrahépatique de la grossesse est un trouble gravidique fréquent qui se manifeste à la fin du deuxième trimestre ou au troisième trimestre (&lt;em&gt;moyenne&lt;/em&gt;).&lt;/p&gt;&lt;/span&gt;&lt;/li&gt;&lt;li&gt;&lt;span&gt;2.&lt;","PeriodicalId":16688,"journal":{"name":"Journal of obstetrics and gynaecology Canada","volume":null,"pages":null},"PeriodicalIF":2.0,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141875128","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Letter to the Editor: Large Databases Cannot Illuminate Practice Variation in the Use of Episiotomy 致编辑的信:大型数据库无法揭示使用外阴切开术的实践差异
IF 2 Q2 OBSTETRICS & GYNECOLOGY Pub Date : 2024-08-01 DOI: 10.1016/j.jogc.2024.102588
Michael C. Klein CM, MD
{"title":"Letter to the Editor: Large Databases Cannot Illuminate Practice Variation in the Use of Episiotomy","authors":"Michael C. Klein CM, MD","doi":"10.1016/j.jogc.2024.102588","DOIUrl":"10.1016/j.jogc.2024.102588","url":null,"abstract":"","PeriodicalId":16688,"journal":{"name":"Journal of obstetrics and gynaecology Canada","volume":null,"pages":null},"PeriodicalIF":2.0,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142048085","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Corrigendum to 2024 Abstracts: 80th Annual Clinical and Scientific Conference [Journal of Obstetrics and Gynaecology Canada (2024) Article Number 102469] 2024 年摘要更正:第80届临床与科学年会[《加拿大妇产科杂志》(2024年)文章编号102469]
IF 2 Q2 OBSTETRICS & GYNECOLOGY Pub Date : 2024-08-01 DOI: 10.1016/j.jogc.2024.102607
JOGC Editorial Office
{"title":"Corrigendum to 2024 Abstracts: 80th Annual Clinical and Scientific Conference [Journal of Obstetrics and Gynaecology Canada (2024) Article Number 102469]","authors":"JOGC Editorial Office","doi":"10.1016/j.jogc.2024.102607","DOIUrl":"10.1016/j.jogc.2024.102607","url":null,"abstract":"","PeriodicalId":16688,"journal":{"name":"Journal of obstetrics and gynaecology Canada","volume":null,"pages":null},"PeriodicalIF":2.0,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S1701216324004304/pdfft?md5=9b7a6c9a3454626082c342eed1578494&pid=1-s2.0-S1701216324004304-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142048087","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
L’avenir du Journal d’obstétrique et gynécologie du Canada : un mot du nouveau rédacteur en chef 加拿大妇产科杂志》的未来:新任主编的话
IF 2 Q2 OBSTETRICS & GYNECOLOGY Pub Date : 2024-08-01 DOI: 10.1016/j.jogc.2024.102630
Graeme N. Smith MD, PhD, FRCSC, FCAHS
{"title":"L’avenir du Journal d’obstétrique et gynécologie du Canada : un mot du nouveau rédacteur en chef","authors":"Graeme N. Smith MD, PhD, FRCSC, FCAHS","doi":"10.1016/j.jogc.2024.102630","DOIUrl":"10.1016/j.jogc.2024.102630","url":null,"abstract":"","PeriodicalId":16688,"journal":{"name":"Journal of obstetrics and gynaecology Canada","volume":null,"pages":null},"PeriodicalIF":2.0,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142048084","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Future of the Journal of Obstetrics and Gynaecology Canada: A Word From its New Editor 加拿大妇产科杂志的未来:新编辑的话
IF 2 Q2 OBSTETRICS & GYNECOLOGY Pub Date : 2024-08-01 DOI: 10.1016/j.jogc.2024.102629
Graeme N. Smith MD, PhD, FRCSC, FCAHS
{"title":"The Future of the Journal of Obstetrics and Gynaecology Canada: A Word From its New Editor","authors":"Graeme N. Smith MD, PhD, FRCSC, FCAHS","doi":"10.1016/j.jogc.2024.102629","DOIUrl":"10.1016/j.jogc.2024.102629","url":null,"abstract":"","PeriodicalId":16688,"journal":{"name":"Journal of obstetrics and gynaecology Canada","volume":null,"pages":null},"PeriodicalIF":2.0,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142048083","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Corrigendum dans la ‘Directive clinique no 422a : Ménopause : symptômes vasomoteurs, agents thérapeutiques d'ordonnance, médecines douces et complémentaires, nutrition et mode de vie’ [J Obstet Gynaecol Can. 43 (2021) 1205-1223.E1] 临床指南第 422a 号:更年期:血管运动症状、处方治疗药物、替代和补充药物、营养和生活方式"[J Obstet Gynaecol Can. 43 (2021) 1205-1223.E1] 中的更正。
IF 2 Q2 OBSTETRICS & GYNECOLOGY Pub Date : 2024-08-01 DOI: 10.1016/j.jogc.2024.102608
Nese Yuksel Pharm. D., Debra Evaniuk M.D., Lina Huang MDCM, Unjali Malhotra M.D., Jennifer Blake M.D., M.Sc., Wendy Wolfman M.D., Michel Fortier M.D.
{"title":"Corrigendum dans la ‘Directive clinique no 422a : Ménopause : symptômes vasomoteurs, agents thérapeutiques d'ordonnance, médecines douces et complémentaires, nutrition et mode de vie’ [J Obstet Gynaecol Can. 43 (2021) 1205-1223.E1]","authors":"Nese Yuksel Pharm. D.,&nbsp;Debra Evaniuk M.D.,&nbsp;Lina Huang MDCM,&nbsp;Unjali Malhotra M.D.,&nbsp;Jennifer Blake M.D., M.Sc.,&nbsp;Wendy Wolfman M.D.,&nbsp;Michel Fortier M.D.","doi":"10.1016/j.jogc.2024.102608","DOIUrl":"10.1016/j.jogc.2024.102608","url":null,"abstract":"","PeriodicalId":16688,"journal":{"name":"Journal of obstetrics and gynaecology Canada","volume":null,"pages":null},"PeriodicalIF":2.0,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S1701216324004316/pdfft?md5=1db5fc45dbc0eaae9833c137480bd46d&pid=1-s2.0-S1701216324004316-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141734359","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Guideline No. 452: Diagnosis and Management of Intrahepatic Cholestasis of Pregnancy 第 452 号指南:妊娠期肝内胆汁淤积症的诊断与管理。
IF 2 Q2 OBSTETRICS & GYNECOLOGY Pub Date : 2024-08-01 DOI: 10.1016/j.jogc.2024.102618
Sebastian R. Hobson MD, PhD, Elissa R. Cohen MD, MA, Shital Gandhi MD, MPH, Venu Jain MD, PhD, Kirsten M. Niles MD, PhD, Marie-Ève Roy-Lacroix MD, Bi Lan Wo MD
<div><h3>Objective</h3><p>To summarize the current evidence and to make recommendations for the diagnosis and management of intrahepatic cholestasis of pregnancy.</p></div><div><h3>Target Population</h3><p>Pregnant people with intrahepatic cholestasis of pregnancy.</p></div><div><h3>Options</h3><p>Diagnosing the condition using fasting or non-fasting bile acids, classifying disease severity, determining what treatment to offer, establishing how to monitor for antenatal fetal wellbeing, identifying when to perform elective birth.</p></div><div><h3>Benefits, Harms, and Costs</h3><p>Individuals with intrahepatic cholestasis of pregnancy are at increased risk of adverse perinatal outcomes including preterm birth, neonatal respiratory distress and admission to a neonatal intensive care unit, with an increased risk of stillbirth when bile acid levels are ≥100 μmol/L. There is inequity in bile acid testing availability and timely access to results, along with uncertainly of how to treat, monitor. and ultimately deliver these pregnancies. Optimization of diagnostic and management protocols can improve maternal and fetal postnatal outcomes.</p></div><div><h3>Evidence</h3><p>Medline, PubMed, Embase, and the Cochrane Library were searched from inception to March 2023, using medical subject headings (MeSH) and keywords related to pregnancy, intrahepatic cholestasis of pregnancy, bile acids, pruritis, ursodeoxycholic acid, and stillbirth. This document presents an abstraction of the evidence rather than a methodological review.</p></div><div><h3>Validation Methods</h3><p>The authors rated the quality of evidence and strength of recommendations using the Grading of Recommendations Assessment, Development and Evaluation (GRADE) approach. See <span><span>Appendix A</span></span> (<span><span>Tables A1</span></span> for definitions and <span><span>A2</span></span> for interpretations).</p></div><div><h3>Intended Audience</h3><p>Obstetric care providers, including obstetricians, family physicians, nurses, midwives, maternal–fetal medicine specialists, and radiologists.</p></div><div><h3>Social Media Abstract</h3><p>Intrahepatic cholestasis of pregnancy requires adequate diagnosis with non-fasting bile acid levels which guide optimal management and delivery timing.</p></div><div><h3>SUMMARY STATEMENTS</h3><p></p><ul><li><span>1.</span><span><p>Intrahepatic cholestasis of pregnancy is a common pregnancy condition manifesting in the late-second or third trimesters (<em>moderate</em>).</p></span></li><li><span>2.</span><span><p>The etiology of intrahepatic cholestasis is complex, involving a combination of hormonal factors, genetic susceptibility, and environmental influences (<em>low</em>).</p></span></li><li><span>3.</span><span><p>Intrahepatic cholestasis remains a diagnosis of exclusion and is based on the presence of maternal pruritis, predominantly of the palms and soles, along with elevated non-fasting bile acids (>19 μmol/L) (<em>moderate</em>).</p></span><
摘要总结现有证据,并为妊娠期肝内胆汁淤积症的诊断和治疗提出建议:目标人群:患有妊娠期肝内胆汁淤积症的孕妇:选择方案:使用空腹或非空腹胆汁酸诊断病情,对疾病严重程度进行分类,确定提供何种治疗,确定如何监测产前胎儿健康状况,确定何时进行选择性分娩:妊娠期肝内胆汁淤积症患者围产期不良结局的风险增加,包括早产、新生儿呼吸窘迫和入住新生儿重症监护室,当胆汁酸水平≥100 μmol/L时,死产风险增加。在胆汁酸检测的可用性和及时获取结果方面存在不公平现象,同时还存在如何治疗、监测和最终分娩这些妊娠的不确定性。优化诊断和管理方案可改善孕产妇和胎儿的产后结局:使用与妊娠、妊娠肝内胆汁淤积症、胆汁酸、瘙痒症、熊去氧胆酸和死胎相关的医学主题词(MeSH)和关键词,对 Medline、PubMed、Embase 和 Cochrane 图书馆进行了从开始到 2023 年 3 月的检索。本文件提供的是证据摘要,而非方法学综述:作者采用建议评估、发展和评价分级法(GRADE)对证据质量和建议强度进行了评级。参见附录 A(定义见表 A1,解释见表 A2):社交媒体摘要:妊娠期肝内胆汁淤积症需要通过非空腹胆汁酸水平进行充分诊断,以指导最佳管理和分娩时机。
{"title":"Guideline No. 452: Diagnosis and Management of Intrahepatic Cholestasis of Pregnancy","authors":"Sebastian R. Hobson MD, PhD,&nbsp;Elissa R. Cohen MD, MA,&nbsp;Shital Gandhi MD, MPH,&nbsp;Venu Jain MD, PhD,&nbsp;Kirsten M. Niles MD, PhD,&nbsp;Marie-Ève Roy-Lacroix MD,&nbsp;Bi Lan Wo MD","doi":"10.1016/j.jogc.2024.102618","DOIUrl":"10.1016/j.jogc.2024.102618","url":null,"abstract":"&lt;div&gt;&lt;h3&gt;Objective&lt;/h3&gt;&lt;p&gt;To summarize the current evidence and to make recommendations for the diagnosis and management of intrahepatic cholestasis of pregnancy.&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Target Population&lt;/h3&gt;&lt;p&gt;Pregnant people with intrahepatic cholestasis of pregnancy.&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Options&lt;/h3&gt;&lt;p&gt;Diagnosing the condition using fasting or non-fasting bile acids, classifying disease severity, determining what treatment to offer, establishing how to monitor for antenatal fetal wellbeing, identifying when to perform elective birth.&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Benefits, Harms, and Costs&lt;/h3&gt;&lt;p&gt;Individuals with intrahepatic cholestasis of pregnancy are at increased risk of adverse perinatal outcomes including preterm birth, neonatal respiratory distress and admission to a neonatal intensive care unit, with an increased risk of stillbirth when bile acid levels are ≥100 μmol/L. There is inequity in bile acid testing availability and timely access to results, along with uncertainly of how to treat, monitor. and ultimately deliver these pregnancies. Optimization of diagnostic and management protocols can improve maternal and fetal postnatal outcomes.&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Evidence&lt;/h3&gt;&lt;p&gt;Medline, PubMed, Embase, and the Cochrane Library were searched from inception to March 2023, using medical subject headings (MeSH) and keywords related to pregnancy, intrahepatic cholestasis of pregnancy, bile acids, pruritis, ursodeoxycholic acid, and stillbirth. This document presents an abstraction of the evidence rather than a methodological review.&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Validation Methods&lt;/h3&gt;&lt;p&gt;The authors rated the quality of evidence and strength of recommendations using the Grading of Recommendations Assessment, Development and Evaluation (GRADE) approach. See &lt;span&gt;&lt;span&gt;Appendix A&lt;/span&gt;&lt;/span&gt; (&lt;span&gt;&lt;span&gt;Tables A1&lt;/span&gt;&lt;/span&gt; for definitions and &lt;span&gt;&lt;span&gt;A2&lt;/span&gt;&lt;/span&gt; for interpretations).&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Intended Audience&lt;/h3&gt;&lt;p&gt;Obstetric care providers, including obstetricians, family physicians, nurses, midwives, maternal–fetal medicine specialists, and radiologists.&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Social Media Abstract&lt;/h3&gt;&lt;p&gt;Intrahepatic cholestasis of pregnancy requires adequate diagnosis with non-fasting bile acid levels which guide optimal management and delivery timing.&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;SUMMARY STATEMENTS&lt;/h3&gt;&lt;p&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;&lt;span&gt;1.&lt;/span&gt;&lt;span&gt;&lt;p&gt;Intrahepatic cholestasis of pregnancy is a common pregnancy condition manifesting in the late-second or third trimesters (&lt;em&gt;moderate&lt;/em&gt;).&lt;/p&gt;&lt;/span&gt;&lt;/li&gt;&lt;li&gt;&lt;span&gt;2.&lt;/span&gt;&lt;span&gt;&lt;p&gt;The etiology of intrahepatic cholestasis is complex, involving a combination of hormonal factors, genetic susceptibility, and environmental influences (&lt;em&gt;low&lt;/em&gt;).&lt;/p&gt;&lt;/span&gt;&lt;/li&gt;&lt;li&gt;&lt;span&gt;3.&lt;/span&gt;&lt;span&gt;&lt;p&gt;Intrahepatic cholestasis remains a diagnosis of exclusion and is based on the presence of maternal pruritis, predominantly of the palms and soles, along with elevated non-fasting bile acids (&gt;19 μmol/L) (&lt;em&gt;moderate&lt;/em&gt;).&lt;/p&gt;&lt;/span&gt;&lt;","PeriodicalId":16688,"journal":{"name":"Journal of obstetrics and gynaecology Canada","volume":null,"pages":null},"PeriodicalIF":2.0,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141875129","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Corrigendum to Database Autopsy: An Efficient and Effective Confidential Enquiry into Maternal Deaths in Canada Journal of Obstetrics and Gynaecology Canada (JOGC). Volume 43, Issue 1 (2021) 58–66 加拿大妇产科杂志》(JOGC),第 43 卷第 1 期(2021 年)58-66。第 43 卷第 1 期(2021 年)58-66。
IF 2 Q2 OBSTETRICS & GYNECOLOGY Pub Date : 2024-08-01 DOI: 10.1016/j.jogc.2024.102615
Amélie Boutin PhD , Arlin Cherian MPH , Jessica Liauw MD, MHSc , Susie Dzakpasu PhD , Heather Scott MD , Michiel Van den Hof MD , Jocelynn Cook PhD , Jennifer Blake MD , K.S. Joseph MD, PhD , Canadian Perinatal Surveillance System (Public Health Agency of Canada)
{"title":"Corrigendum to Database Autopsy: An Efficient and Effective Confidential Enquiry into Maternal Deaths in Canada Journal of Obstetrics and Gynaecology Canada (JOGC). Volume 43, Issue 1 (2021) 58–66","authors":"Amélie Boutin PhD ,&nbsp;Arlin Cherian MPH ,&nbsp;Jessica Liauw MD, MHSc ,&nbsp;Susie Dzakpasu PhD ,&nbsp;Heather Scott MD ,&nbsp;Michiel Van den Hof MD ,&nbsp;Jocelynn Cook PhD ,&nbsp;Jennifer Blake MD ,&nbsp;K.S. Joseph MD, PhD ,&nbsp;Canadian Perinatal Surveillance System (Public Health Agency of Canada)","doi":"10.1016/j.jogc.2024.102615","DOIUrl":"10.1016/j.jogc.2024.102615","url":null,"abstract":"","PeriodicalId":16688,"journal":{"name":"Journal of obstetrics and gynaecology Canada","volume":null,"pages":null},"PeriodicalIF":2.0,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S1701216324004389/pdfft?md5=acd7be936704e4b61ed9d29d16b72920&pid=1-s2.0-S1701216324004389-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141766385","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prospective Evaluation of Ease and Difficulties of 869 Cases of Intrauterine Devices Removals 对 872 例宫内节育器取出手术的难易程度进行前瞻性评估。
IF 2 Q2 OBSTETRICS & GYNECOLOGY Pub Date : 2024-07-26 DOI: 10.1016/j.jogc.2024.102616
Jacques B.E. Versailles MD, MSc, Luis Bahamondes MD, PhD, Ana Claudia Marcelino MD, MC, Paula da Cunha Pereira RN, MC, Cassia R.T. Juliato MD, PhD

Objectives

The objective was to describe the ease and difficulty of removing intrauterine devices (IUDs).

Methods

We conducted a prospective study at the University of Campinas (UNICAMP), Faculty of Medical Sciences, UNICAMP. We included women who requested IUD removal. We excluded women with partial IUD expulsion in which the IUD was protruded at the external os. We identified difficult IUD removal when the removal was challenging, including the inability to visualize IUD strings extending from the cervical os.

Results

A total of 869 women participated. Women were aged 29.4 ± 8.0 years (mean ± SD; range 14–51) and the duration of IUD use at the time of removal was 4.3 ± 4.2 years. We found that 702 (80.8%) women had visible strings at the external os and the removals were performed at the first attempt without difficulty in 692 (79.6%) participants. The pain was more intense (>4) in cases of difficult removals. After multivariate logistic analysis, difficult removals were associated with users of IUD ≥3 years (3 times higher risk); for each previous cesarean delivery, the risk increased by 1.5 times.

Conclusions

Our study showed that IUD removal is an easy and safe procedure, with only a small proportion of women reporting significant pain with IUD removal.

目的:描述取出宫内节育器(IUD)的难易程度:目的是描述取出宫内节育器(IUD)的难易程度:我们在 XXXX 医学院 XXXX 大学开展了一项前瞻性研究。我们纳入了要求取出宫内节育器的妇女。我们排除了部分宫内节育器被取出的妇女,因为这些妇女的宫内节育器突出于子宫外口。如果取出宫内节育器具有挑战性,包括无法看到宫颈口处延伸的宫内节育器线,我们将确定为难以取出宫内节育器:共有 869 名妇女参与。妇女的年龄为 29.4 ± 8.0 岁(平均 ± SD;范围 14-51),取出宫内节育器时的使用时间为 4.3 ± 4.2 年。我们发现,702 名妇女(80.8%)的宫颈外口有明显的线,692 名妇女(79.6%)在第一次尝试时就顺利取出了宫内节育器。在难以取出的病例中,疼痛更为剧烈(>4 级)。经过多变量逻辑分析,难以取出宫内节育器与使用宫内节育器超过 3 年有关(风险高出 3 倍);以前每进行一次剖宫产,风险就增加 1.5 倍:我们的研究表明,取出宫内节育器是一项简单而安全的手术,只有一小部分妇女表示在取出宫内节育器时有明显的疼痛感。
{"title":"Prospective Evaluation of Ease and Difficulties of 869 Cases of Intrauterine Devices Removals","authors":"Jacques B.E. Versailles MD, MSc,&nbsp;Luis Bahamondes MD, PhD,&nbsp;Ana Claudia Marcelino MD, MC,&nbsp;Paula da Cunha Pereira RN, MC,&nbsp;Cassia R.T. Juliato MD, PhD","doi":"10.1016/j.jogc.2024.102616","DOIUrl":"10.1016/j.jogc.2024.102616","url":null,"abstract":"<div><h3>Objectives</h3><p>The objective was to describe the ease and difficulty of removing intrauterine devices (IUDs).</p></div><div><h3>Methods</h3><p>We conducted a prospective study at the University of Campinas (UNICAMP), Faculty of Medical Sciences, UNICAMP. We included women who requested IUD removal. We excluded women with partial IUD expulsion in which the IUD was protruded at the external os. We identified difficult IUD removal when the removal was challenging, including the inability to visualize IUD strings extending from the cervical os.</p></div><div><h3>Results</h3><p>A total of 869 women participated. Women were aged 29.4 ± 8.0 years (mean ± SD; range 14–51) and the duration of IUD use at the time of removal was 4.3 ± 4.2 years. We found that 702 (80.8%) women had visible strings at the external os and the removals were performed at the first attempt without difficulty in 692 (79.6%) participants. The pain was more intense (&gt;4) in cases of difficult removals. After multivariate logistic analysis, difficult removals were associated with users of IUD ≥3 years (3 times higher risk); for each previous cesarean delivery, the risk increased by 1.5 times.</p></div><div><h3>Conclusions</h3><p>Our study showed that IUD removal is an easy and safe procedure, with only a small proportion of women reporting significant pain with IUD removal.</p></div>","PeriodicalId":16688,"journal":{"name":"Journal of obstetrics and gynaecology Canada","volume":null,"pages":null},"PeriodicalIF":2.0,"publicationDate":"2024-07-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141788442","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Journal of obstetrics and gynaecology Canada
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1